VANCOUVER, BC, March 16, 2022 – PanGenomic Health Inc. (the “Company” or “PanGenomic Health”) is pleased to announce that it has released its beta version of the Nara app that provides consumers with personalized information about natural remedy solutions to support mental health. Access to the Nara app can be obtained at www.nara.care. PanGenomic Health expects the Nara mental health app to be available on the Apple App Store by June 2022.
About PanGenomic Health
PanGenomic Health Inc. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. Registered as a public benefit corporation, the Company’s mission is to improve the health and wellness of people by providing a technology platform that identifies natural treatments tailored to the health profile of each individual.
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risk that the anticipated benefits of the transaction will be realized as contemplated, or at all, risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The statements in this news release are made as of the date of this release.